Metabolic pathways associated with KRAS mutations include aminoacyl‐tRNA biosynthesis, amino acid metabolism (Pupo et al, 2019) and notably a pathway suspected to be essential for cancer survival: glutamine and glutamate metabolism (Cluntun et al, 2017). The gene discussed is KRAS; the disease is cancer.